Crossmark

Cancer neoantigens as potential targets for immunotherapy

Published Online: 2021-05-05

Published Print: 2022-02

Authors

Ma, Weijie

Pham, Brian

Li, Tianhong https://orcid.org/0000-0001-7422-3520
Funding

Funding for this research was provided by:

Biomedical Laboratory Research and Development, VA Office of Research and Development (I01 BX003895)
License Information

Text and Data Mining valid from 2021-05-05

Version of Record valid from 2021-05-05
More Information

Article History

Received: 7 November 2020

Accepted: 22 March 2021

First Online: 5 May 2021

Document is current